A Clinical Study to Assess the Efficacy and Safety of SED80 for Use in Cataract Surgery

NCT04711213 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataract in Inflammatory Ocular Disorders

Interventions

DRUG: Dexamethasone Dose 1
DRUG: Dexamethasone Dose 2
DRUG: Placebo Dose 1
DRUG: Placebo Dose 2

Sponsor

iDrop, Inc.